Articles by T Okusaka (5)

Four Cases of Pancreatic Acinar Cell Carcinoma Treated with Gemcitabine or S-1 as a Single Agent

Y Seki, T Okusaka, M Ikeda, C Morizane and H. Ueno

Japanese Journal of Clinical Oncology 39 ( 11 ): 751 - 755 , 2009

Regular Dose of Gemcitabine Induces an Increase in CD14+ Monocytes and CD11c+ Dendritic Cells in Patients with Advanced Pancreatic Cancer

A Soeda, Y Morita Hoshi, H Makiyama, C Morizane, H Ueno, M Ikeda, T Okusaka, S Yamagata, N Takahashi, I Hyodo, Y Takaue and Y. Heike

Japanese Journal of Clinical Oncology 39 ( 12 ): 797 - 806 , 2009

Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas

S Iwasa, C Morizane, T Okusaka, H Ueno, M Ikeda, S Kondo, T Tanaka, K Nakachi, S Mitsunaga, Y Kojima, A Hagihara and N. Hiraoka

Japanese Journal of Clinical Oncology 40 ( 4 ): 313 - 318 , 2010

Long-Term Administration of Wilms Tumor-1 Peptide Vaccine in Combination with Gemcitabine Causes Severe Local Skin Inflammation at Injection Sites

A Soeda, Y Morita Hoshi, M Kaida, T Wakeda, Y Yamaki, Y Kojima, H Ueno, S Kondo, C Morizane, M Ikeda, T Okusaka and Y. Heike

Japanese Journal of Clinical Oncology 40 ( 12 ): 1184 - 1188 , 2010

Randomized Phase II Study of Gemcitabine plus S-1 Combination Therapy vs. S-1 in Advanced Biliary Tract Cancer: Japan Clinical Oncology Group Study (JCOG0805)

A Takashima, C Morizane, H Ishii, K Nakamura, H Fukuda, T Okusaka and J. Furuse

Japanese Journal of Clinical Oncology 40 ( 12 ): 1189 - 1191 , 2010